Viva Viral Vaccines, Inc.
- UEI
- W33PRUFFPWB7
- CAGE
- 9U3D5
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Broad-spectrum, multivalent platform for pan-influenza vaccine | National Institute of Allergy and Infectious Diseases (NIH) | $299,968 |
Quick answers
Is Viva Viral Vaccines, Inc. registered in SAM.gov?
Viva Viral Vaccines, Inc.'s SAM.gov registration expired on February 6, 2026.
What is Viva Viral Vaccines, Inc.'s most recent federal award?
Viva Viral Vaccines, Inc.'s most recent federal grant award is Broad-spectrum, multivalent platform for pan-influenza vaccine (R41AI195180), from National Institute of Allergy and Infectious Diseases (NIH), on September 25, 2025.
On GovTribe
See Viva Viral Vaccines, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors